The global radiation therapy quality assurance (QA) phantoms market is expected to reach a market size of USD 36.4 Million by 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Quality check and assurance before delivering radiation treatment to a cancer patient is critical in order to maintain the radiation dose as prescribed by the doctor. Some major drivers fueling growth of the global market include enhancement of patient and machine quality assurance in radiation oncology, rising demand for tissue equivalent phantoms, and increasing number of cancer patients globally. https://www.emergenresearch.com/industry-report/radiation-therapy-quality-assurance-phantoms-market